Feedback (LSE:FDBK) Market Cap: £3.11 Mil (As of Jun. 30, 2026)


What is Feedback Market Cap?

Feedback LSE:FDBK Market Cap is £3.11 Mil as of Jun. 30, 2026. The stock has 4 warning signs investors should review. Among 694 Healthcare Providers & Services companies, Feedback ranks worse than 90.78% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Feedback's share price for the quarter that ended in Nov. 2025 was £0.07975. Feedback's Shares Outstanding (EOP) for the quarter that ended in Nov. 2025 was 43.82 Mil. Therefore, Feedback's market cap for the quarter that ended in Nov. 2025 was £3.49 Mil.

Feedback's quarterly market cap declined from Nov. 2024 (£8.76 Mil) to May. 2025 (£6.35 Mil) and declined from May. 2025 (£6.35 Mil) to Nov. 2025 (£3.49 Mil).

Feedback's annual market cap declined from May. 2023 (£15.34 Mil) to May. 2024 (£9.47 Mil) and declined from May. 2024 (£9.47 Mil) to May. 2025 (£6.35 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Feedback's Enterprise Value for Today is £-0.71 Mil.


Feedback  (LSE:FDBK) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Feedback Market Cap Related Terms


Feedback Market Cap Historical Data

* Premium members only.

The historical data trend for Feedback's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Feedback Market Cap Chart

Feedback Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.47 16.67 15.34 9.47 6.35

Feedback Semi-Annual Data
May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.60 9.47 8.76 6.35 3.49

LSE:FDBK vs VEEV, BTSG, TEM: Market Cap Comparison

For the Health Information Services subindustry, Feedback's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feedback Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Feedback's Market Cap distribution charts can be found below:

* The bar in red indicates where Feedback's Market Cap falls into.



Feedback Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Feedback's Market Cap for the fiscal year that ended in May. 2025 is calculated as

Market Cap (A: May. 2025 )=Share Price (A: May. 2025 )*Shares Outstanding (EOP) (A: May. 2025 )
=£0.145*43.815
=£6.35

Feedback's Market Cap for the quarter that ended in Nov. 2025 is calculated as

Market Cap (Q: Nov. 2025 )=Share Price (Q: Nov. 2025 )*Shares Outstanding (EOP) (Q: Nov. 2025 )
=£0.07975*43.815
=£3.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of £3.11 Mil mean?
Feedback (LSE:FDBK) has a Market Cap of £3.11 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Feedback and its competitors. According to the industry distribution chart, Feedback ranks #630 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 90.8%.
Is Feedback's Market Cap too high?
Feedback's current Market Cap is £3.11 Mil. Based on the distribution chart, Feedback ranks #630 out of 694 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Feedback's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Feedback ranks #630 out of 694 companies for Market Cap. This places Feedback in the lower half of its industry. The industry median Market Cap is 93.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Feedback and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feedback's current Market Cap is £3.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feedback stock overvalued right now?
Based on GuruFocus' analysis, Feedback (LSE:FDBK) is currently considered Possible Value Trap. The stock's GF Value™ is £0.14, compared to a current price of £0.07 — trading 49.3% below its estimated fair value. The current Market Cap is £3.11 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Feedback (LSE:FDBK), the current Market Cap is £3.11 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Feedback Business Description

Other Exchanges GZM0:Germany
Address 3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making, and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. Its operating segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa, a regulated communication platform for sharing clinical results and supporting multidisciplinary teamwork, and CareLocker, a patient-facing platform that provides access and control over diagnostic and clinical data.